Anavex Life Sciences Corp (AVXL)

[frrol]

No "dove-tailing" for many reasons. The protocol for the Phase 2/3 will be different and has not been established yet, let alone approved. It might not even be in Australia.

The Phase 2A participants that just finished their 52-week Part B either requested another extension or they didn't. And if they did, the company either granted that extension or it didn't. One thing is for certain: it would have happened by now, and Missling didn't say anything about it if it did happen.

So probability is very high there is no additional extension, which would be disappointing for several important reasons. Ah well.